Company intelligence / Profile preview
Bazelet Pharma
Or Akiva, Israel
- Ownership
- Private
- Development stage
- Other
01
Overview
Bazelet Pharma (part of the Bazelet Group) is the largest medical cannabis processing company in Israel, operating EU‑GMP/IMC‑GMP facilities in Israel and Malta and commercializing over 80 approved terpene‑enriched cannabis oil products and branded flower/oil lines (e.g., Bcann, Femmican, Silver, ASD) for multiple patient populations.[1][2]
- Therapeutic areas
- OtherPsychiatryNeurologyWomen's Health
- Modalities
- Small moleculePlant extractDevice
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
RYAH Group (memorandum of understanding for Israel distribution and regulatory sponsorship of the RYAH Smart Inhaler for medical cannabis)[2]
Beyond the preview
Go deeper on Bazelet Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bazelet Pharma.